Page last updated: 2024-10-26

diphenyleneiodonium and Diabetic Retinopathy

diphenyleneiodonium has been researched along with Diabetic Retinopathy in 2 studies

diphenyleneiodonium: structure in first source; NADPH oxidase inhibitor
dibenziodolium : An organic cation that is fluorene in which the methylene group is replaced by a positively charged iodine.

Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tawfik, A1
Sanders, T1
Kahook, K1
Akeel, S1
Elmarakby, A1
Al-Shabrawey, M1
Li, L1
Renier, G1

Other Studies

2 other studies available for diphenyleneiodonium and Diabetic Retinopathy

ArticleYear
Suppression of retinal peroxisome proliferator-activated receptor gamma in experimental diabetes and oxygen-induced retinopathy: role of NADPH oxidase.
    Investigative ophthalmology & visual science, 2009, Volume: 50, Issue:2

    Topics: Acetophenones; Animals; Blotting, Western; Cell Culture Techniques; Diabetes Mellitus, Experimental;

2009
Activation of nicotinamide adenine dinucleotide phosphate (reduced form) oxidase by advanced glycation end products links oxidative stress to altered retinal vascular endothelial growth factor expression.
    Metabolism: clinical and experimental, 2006, Volume: 55, Issue:11

    Topics: Acetophenones; Animals; Blotting, Western; Cattle; Diabetic Retinopathy; Endothelial Cells; Enzyme A

2006